Friday, February 20, 2026
21 C
Bengaluru

Is Your Career Headed in the Right Direction?

Make Sure You’re Moving in the Right Direction… Digital, Phygital, or F2F

Workshop Lead Faculty – Salil Kallianpur

Workshop Moderator – Anup Soans

European Case Study Presentation – Dr. Peter Velev, CEO @ EcoPharma and Founder @ CredoWeb

Indian Case Study – Praful Akali – MD @ Medulla Communications

Join #MedicinMan Moving from Digital Noise to Digital Voice 4-Module Workshop, 4 Saturdays, 5 PM to 7 PM beginning Saturday 30th October and 13th Nov, 20th Nov and 27th Nov

Only 20 participants per batch to ensure personalization – 5 seats remaining.

Enroll Now… https://lnkd.in/gVfSzhyn

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img